These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22735717)

  • 1. Nonsurgical therapy for heart failure.
    Park KW
    Int Anesthesiol Clin; 2012; 50(3):1-21. PubMed ID: 22735717
    [No Abstract]   [Full Text] [Related]  

  • 2. The Vulnerable Phase of Heart Failure.
    Gracia E; Singh P; Collins S; Chioncel O; Pang P; Butler J
    Am J Ther; 2018; 25(4):e456-e464. PubMed ID: 29985824
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note.
    Tang WH; Francis GS
    Circulation; 2011 Jan; 123(2):203-8. PubMed ID: 21242506
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic heart failure].
    Nowak B
    MMW Fortschr Med; 2013 Nov; 155 Spec No 2():76-80; quiz 81. PubMed ID: 24734463
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac resynchronization therapy: what? Who? When? How?
    Cuculich PS; Joseph S
    Am J Med; 2011 Sep; 124(9):813-5. PubMed ID: 21854888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of defibrillators and resynchronization therapy at the time of evaluation at a heart failure and cardiac transplantation center.
    Sims DB; Garcia LI; Mignatti A; Colombo PC; Jones M; Uriel N; Mancini DM; Jorde UP
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):988-93. PubMed ID: 20353413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How to treat heart failure successfully].
    Zobel C
    MMW Fortschr Med; 2013 Mar; 155(4):41-6. PubMed ID: 23614195
    [No Abstract]   [Full Text] [Related]  

  • 8. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%).
    Lam CS; Solomon SD
    Eur J Heart Fail; 2014 Oct; 16(10):1049-55. PubMed ID: 25210008
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of phase II acute heart failure syndromes clinical trials.
    Pang PS; Gheorghiade M
    Heart Fail Clin; 2011 Oct; 7(4):441-50. PubMed ID: 21925427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy for mild congestive heart failure.
    Technol Eval Cent Assess Program Exec Summ; 2010 Apr; 24(8):1-5. PubMed ID: 20575185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned from clinical trials in acute heart failure: phase 3 drug trials.
    O'Connor CM; Fiuzat M
    Heart Fail Clin; 2011 Oct; 7(4):451-6. PubMed ID: 21925428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreseeing super-response to cardiac resynchronization therapy: a perspective for clinicians.
    Ellenbogen KA; Huizar JF
    J Am Coll Cardiol; 2012 Jun; 59(25):2374-7. PubMed ID: 22698491
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.
    Ellenbogen KA; Gold MR; Meyer TE; Fernndez Lozano I; Mittal S; Waggoner AD; Lemke B; Singh JP; Spinale FG; Van Eyk JE; Whitehill J; Weiner S; Bedi M; Rapkin J; Stein KM
    Circulation; 2010 Dec; 122(25):2660-8. PubMed ID: 21098426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resynchronization therapy for heart failure--still many question marks].
    Murín P; Mitro P; Valocik G; Stancák B
    Vnitr Lek; 2011 Oct; 57(10):819-25. PubMed ID: 22097690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine-induced cardiomyopathy: a case report.
    Muthukrishnan P; Roukoz H; Grafton G; Jessurun J; Colvin-Adams M
    Circ Heart Fail; 2011 Mar; 4(2):e7-8. PubMed ID: 21406675
    [No Abstract]   [Full Text] [Related]  

  • 18. Vulnerability in Heart Failure.
    Hauptman PJ
    J Card Fail; 2018 Aug; 24(8):485-486. PubMed ID: 30219213
    [No Abstract]   [Full Text] [Related]  

  • 19. Heart failure epidemic boiling to the surface.
    Rasmusson KD; Hall JA; Renlund DG
    Nurse Pract; 2006 Nov; 31(11):12-21; quiz 21-3. PubMed ID: 17122739
    [No Abstract]   [Full Text] [Related]  

  • 20. Integration of remote monitoring of device diagnostic parameters into a multidisciplinary heart failure management program.
    Dierckx R; Houben R; Goethals M; Verstreken S; Bartunek J; Saeys R; De Proft M; Boel E; Vanderheyden M
    Int J Cardiol; 2014 Apr; 172(3):606-7. PubMed ID: 24507743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.